Products in this category recombine a fairly short list of ingredients. Once you know what each one actually has behind it, evaluating any new product becomes a matter of reading the label.
The ingredient reference
| Ingredient | Proposed mechanism | Evidence strength |
|---|---|---|
| Fermentable fibre (inulin, resistant starch, oat beta glucan) | Fermented to short-chain fatty acids that stimulate GLP-1 release | Strongest. Established physiology, plus a 192-participant RCT for one product |
| Protein | Stimulates satiety hormones; preserves lean mass in a deficit | Strong, and the best-evidenced intervention in this whole category |
| myHMB (beta-hydroxy beta-methylbutyrate) | Preserves lean muscle mass during a caloric deficit | Reasonable published research, aimed at the actual clinical risk |
| Bitter hops extract (Amarasate) | Bitter compounds trigger gut hormone release in the small intestine | Four published studies including AJCN 2022; effect size modest |
| Akkermansia muciniphila | Gut barrier integrity and metabolic regulation | Two decades of research, largely preclinical rather than human outcomes |
| Berberine | Triggers AMPK, an enzyme controlling metabolism and energy | Genuine metabolic research; no conclusive evidence it matches GLP-1s |
| Saffron extract (Supresa) | Reduced snacking and appetite | Ingredient-level studies reporting reduced snacking |
| Red orange extract (Morosil) | Body composition | Ingredient-level studies; not studied in most finished products |
| Lemon bioflavonoid (Eriomin) | Increases GLP-1 levels | Cited at around a 17% increase, with no weight loss demonstrated |
| Clostridium butyricum | Produces butyrate, fuelling gut lining cells | Mechanistic; limited human outcome data |
| Bifidobacterium infantis | Gut inflammation and immune balance | Mechanistic; limited human outcome data for metabolic ends |
| Electrolytes (magnesium, potassium, sodium) | Replaces losses from reduced intake | Sound rationale; addresses a real problem rather than a hormonal one |
| B12, vitamin D, calcium | Fills micronutrient gaps from eating less | Sound where an actual deficiency exists; testing beats guessing |
Evidence strength refers to human outcome data. Several ingredients have promising preclinical work that has not yet translated into demonstrated results in people.
How to use this table
Take any product in this category, read its Supplement Facts panel, and check each ingredient against the rows above. If the formula is mostly ingredients from the bottom half of the table, you are buying a hypothesis. If it is mostly from the top, you are buying something with a defensible rationale.
Then check the amounts. An ingredient with good evidence at 1 gram is not the same ingredient at 100mg, and a proprietary blend total tells you nothing at all. Our label guide covers that step.
The ingredients doing the most work
Protein and fibre
Between them they address muscle preservation, satiety, constipation and glycaemic response. They are also the cheapest and least marketed things in the category, available from food.
myHMB
The one branded ingredient aimed squarely at the real clinical risk during rapid weight loss. Appears in the Vitamin Shoppe and Youtheory protein products.
Electrolytes and micronutrients
Unglamorous, cheap and genuinely relevant when intake falls. Worth pairing with actual bloodwork rather than guessing.
Everything else
Ranges from promising to unsupported. Interesting, worth watching, and not yet a reason to spend a lot of money.
Supplements are not medication
Nothing on this page is a prescription GLP-1 medication or a substitute for one. Dietary supplements are not approved by the FDA before sale, their claims are not evaluated by the FDA, and they are not intended to diagnose, treat, cure or prevent any disease. No supplement covered here has been shown to produce weight loss comparable to semaglutide or tirzepatide.
Speak to a clinician before starting any supplement, particularly if you take prescription medication, are pregnant or breastfeeding, are immunocompromised, or have a diagnosed condition. See our full medical disclaimer.
A note on how evidence gets presented
Watch for three moves. Evidence for an ingredient presented as evidence for a product. A percentage change in a biomarker presented as a clinical outcome. And trial data for prescription medications placed near a supplement's own claims, inviting a comparison nobody has actually made. Our evidence review works through the specific examples.
Frequently Asked Questions
Which GLP-1 supplement ingredient has the best evidence?
Fermentable fibre, followed by protein. Both have established mechanisms and address problems GLP-1 patients genuinely have. Neither is exotic, and both are available from food far more cheaply than from a supplement.
Is Akkermansia worth taking?
The research linking it to gut barrier integrity and metabolic regulation is genuine but largely preclinical. Pendulum, a specialist manufacturer, states on its own product page that its evidence is preclinical and the product is not intended for weight loss.
What is myHMB?
A branded form of beta-hydroxy beta-methylbutyrate with published research on preserving lean muscle mass during a caloric deficit. It targets the actual clinical risk of rapid weight loss rather than a marketing construct.
Does Eriomin work?
It is cited in its own supporting study as increasing GLP-1 by around 17 percent, with no weight loss demonstrated. A class action against one product containing it makes that distinction central to its allegations.
How do I check whether an ingredient is at a useful dose?
Find the dose used in the research, then check the Supplement Facts panel for the amount per serving. Berberine research used around 1 gram daily, for example. A proprietary blend total makes this check impossible.
Should I buy a product with many ingredients or few?
Neither is inherently better. What matters is whether the ingredients present have evidence and whether they are at studied doses. A long ingredient list at token amounts is worse than a short one at meaningful doses.
Medical Disclaimer
This article is for general information only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who knows your history can decide whether any medication is appropriate for you. Pricing, programmes and policies described here reflect what providers published at the time of writing and change frequently; verify everything directly before enrolling. See our full medical disclaimer.